Proteomics International Launches Share Purchase Plan
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Proteomics International Laboratories Ltd has launched a Share Purchase Plan to invite eligible shareholders to participate in raising funds. The plan aims to raise funds for commercial execution, clinical programs, and market readiness initiatives. Eligible shareholders can subscribe for new shares at a discounted price, with additional options offered as incentives. An investor webinar is scheduled to discuss the plan and recent company progress.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Proteomics International Laboratories Ltd. on 6ix
In the deck
Earlier from Proteomics International Laboratories
- Quarterly Activities/Appendix 4C Cash Flow Report
- National Rollout of PromarkerD and PromarkerEso
- Proteomics International receives $2.0m in R&D tax incentive
- PromarkerEndo Validation and Refinement Complete
- PromarkerD and PromarkerEso Commercial Rollout Update
Later from Proteomics International Laboratories
- Share Purchase Plan Cleansing Notice
- Security Purchase Plan Offer Booklet
- Investor Webinar Presentation
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories